✦ LIBER ✦

Interferon β1a Treatment Modulates TH1 Expression in γδ + T Cells from Relapsing-Remitting Multiple Sclerosis Patients

✍ Scribed by Cerise L. Elliott; Samia Y. Ei-Touny; Mary L. Filipi; Kathleen M. Healey; M. Patricia Leuschen

Book ID: 110296863
Publisher: Springer
Year: 2001
Tongue: English
Weight: 72 KB
Volume: 21
Category: Article
ISSN: 0271-9142
DOI: 10.1023/a:1011043417159

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon β-1b modulates MCP-1 expressi

Interferon β-1b modulates MCP-1 expression and production in relapsing–remitting multiple sclerosis

✍ Carla Iarlori; Marcella Reale; Giovanna De Luca; Angelo Di Iorio; Claudio Felici 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 266 KB

RANTES production and expression is redu

RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-β-1b

✍ Carla Iarlori; Marcella Reale; Alessandra Lugaresi; Giovanna De Luca; Laura Bona 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 258 KB

Interferon-β1b treatment modulates cytok

Interferon-β1b treatment modulates cytokines in patients with primary progressive multiple sclerosis

✍ A. Dressel; A. K. Kolb; E. Elitok; A. Bitsch; T. Bogumil; B. Kitze; H. Tumani; F 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

Magnetic resonance imaging outcome of ne

Magnetic resonance imaging outcome of new enhancing lesions in relapsing-remitting multiple sclerosis patients treated with interferon β1a

✍ Andrea Paolillo; S. Bastianello; Marco Frontoni; Claudio Gasperini; Elisabetta G 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 58 KB

pSTAT1, pSTAT3, and T-bet expression in

pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity

✍ Giovanni Frisullo; Francesco Angelucci; Marcella Caggiula; Viviana Nociti; Raffa 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 665 KB

## Abstract Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system, and it is considered to be a T helper 1 (Th1) cell‐mediated autoimmune disease. T‐bet has been identified as a key transcription factor for the development of Th1 cells and the inducti

Incidence of exacerbations in the first

Incidence of exacerbations in the first 90 days of treatment with recombinant human interferon β-1b in patients with relapsing-remitting multiple sclerosis

✍ Dr. Omar A. Khan; J. Richard Hebel 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB 👁 1 views